New research from Michigan Medicine could help improve treatment and outcomes for patients with triple-negative breast cancer brain metastases. Nathan Merrill, Ph.D., assistant professor of hematology/oncology at Michigan Medicine and corresponding author on a new paper, shares insights from his findings and approach.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.